UK markets close in 1 hour 30 minutes

Mereo BioPharma Group plc (MREO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.5080+0.0213 (+4.38%)
As of 09:57AM EDT. Market open.
Show:
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
36,464
36,464
0
0
0
Cost of revenue
17,908
17,908
16,347
23,608
22,704
Gross profit
18,556
18,556
-16,347
-23,608
-22,704
Operating expenses
Research development
23,559
23,559
-
-
22,704
Selling general and administrative
15,933
15,933
21,222
15,909
12,505
Total operating expenses
39,492
39,492
21,222
15,909
12,505
Operating income or loss
-20,936
-20,936
-37,569
-39,517
-35,208
Interest expense
4,001
4,001
6,383
4,827
3,055
Total other income/expenses net
39,198
39,198
-122,542
1,974
-65.766
Income before tax
14,241
14,241
-166,450
-41,118
-37,306
Income tax expense
1,516
1,516
-2,822
-6,274
-5,277
Income from continuing operations
12,725
12,725
-163,628
-34,844
-32,029
Net income
12,725
12,725
-163,628
-34,844
-32,029
Net income available to common shareholders
12,725
12,725
-163,628
-34,844
-32,029
Basic EPS
-
-
-2.40
-1.95
-2.25
Diluted EPS
-
-
-2.40
-1.95
-2.25
Basic average shares
-
-
68,178
17,885
14,229
Diluted average shares
-
-
68,178
17,885
14,229
EBITDA
-
18,884
-158,468
-34,714
-34,213